羊奶全方位配方与乳清奶牛奶配方:婴儿更喜欢哪种配方?-可行性,双盲,随机受控试验
Camille Jung1,2, Adolfo González Serrano2, Christophe Batard3
1Clinical Research Center, Centre Hospitalier Intercommunal de Créteil, 94000 Créteil, France.
Nutrients
|September 28, 2023
概括
羊奶配方 (GMF) 与牛奶配方 (CMF) 相比,改善了婴儿的食欲和生活质量. 这项研究表明,GMF是婴儿养的有益替代品,在食物享受方面没有差异.
科学领域:
- 儿科 儿科 儿科
- 营养科学 营养科学
- 婴儿健康 婴儿健康
背景情况:
- 羊奶配方 (GMF) 为婴儿提供了牛奶配方 (CMF) 的替代品.
- 婴儿养行为和GMF和CMF之间的生活质量差异尚未得到广泛的研究.
- 这项研究解决了评估婴儿对GMF和CMF的反应的需要.
研究的目的:
- 为了确定基于全牛奶的GMF是否会导致婴儿的养行为问题比基于乳清的CMF更少.
- 为了比较GMF和CMF群体之间的婴儿养行为和生活质量.
- 评估配方类型对婴儿食欲和发育的影响.
主要方法:
- 一个多中心,双盲,随机对照试验,涉及64名健康婴儿 (≤4个月).
- 婴儿被分配给基于全乳的GMF或基于乳清的CMF.
- 父母在基线和28日完成了婴儿饮食行为问卷 (BEBQ) 和修改的QUALIN问卷.
主要成果:
- 与CMF相比,被GMF养的婴儿在食物反应 (p=0.010) 和一般食欲 (p=0.012) 中显著改善.
- 转基因食组在修改后的QUALIN分数 (p=0.03) 中也显著改善,表明生活质量更好.
- 两组之间在BEBQ享受食物或缓慢进食分量级分数中没有发现显著差异.
结论:
- 与乳清基CMF相比,全乳基GMF可能会提高婴儿的一般食欲和生活质量.
- 配方之间蛋白质和脂质配置的潜在差异可能解释了观察到的效应.
- 在婴儿养中,GMF为CMF提供了一个有前途的替代品,对食欲和幸福感产生积极影响.
相关概念视频
Imprinting
Behavioral imprinting is observed in some newborn animals and occurs when they develop strong and specific attachments to another animal (usually a parent) following brief, early-life exposures. Offspring imprint onto parents within a brief period after birth or hatching; this time window is called the critical period. Once imprinting occurs, the bond established between the parents and their offspring is usually long-lasting.
Cloning of Dolly the Sheep
The first successfully cloned mammal was Dolly, a sheep, born on 5th July 1996 at Roslin Institute, Scotland. The cloned sheep was named after the American singer Dolly Parton. Dolly lived for seven years and died of respiratory complications, which is speculated to be due to the actual age of her DNA. Because the DNA in cloned cells belongs to an older individual, the cloned individual’s life expectancy may be affected. Indeed, analysis of Dolly’s DNA revealed shorter telomeres than other...
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...


